Navigation Links
VIB exceptionally sceptical about the Sralini research
Date:9/20/2012

The VIB scientists had serious reservations about the Sralini publication, which appeared today in the journal Food and Chemical Toxicology. The conclusions drawn by Sralini could not be derived from the publication. The data will have to be subjected to a thorough analysis.

VIB points out that Sralini is a controversial researcher. "Sralini has published similar accounts before, but not one of them has withstood scientific scrutiny. That is because he draws conclusions that cannot be derived from the data. The European Food Safety Authority (EFSA) has examined Sralini's previous study about GM maize for the European Commission. His conclusions were not followed on the basis of sound scientific elements and the EFSA repeated its recommendations concerning GM maize."

VIB emphasized the many studies that have demonstrated the safety of GM maize. "In the United States transgenic maize has been grown for seventeen years for human consumption and as cattle feed. These crops were naturally subjected to the toxicity tests required for commercial use and were found to be safe. In view of the polarization surrounding GM crops in Europe, a massive number of studies have already been carried out into possible toxic effects of GM crops. These have shown that GM crops are as safe for human and animal consumption as non-GM crops.

VIB is a proponent of studies concerning the safety of GM crops but insists that these have to be carried out in a thorough and scientifically responsible way. VIB regrets that incorrectly performed studies damage the reputation of GM organisms and plant biotechnology in general.


'/>"/>

Contact: Kris Van der Beken
kris.vanderbeken@vib.be
32-473-783-435
VIB (the Flanders Institute for Biotechnology)
Source:Eurekalert

Page: 1

Related biology news :

1. VIB exceptionally sceptical about the Séralini research
2. Teaching about hearing can save young peoples ears
3. A birds song may teach us about human speech disorders
4. Fielding questions about climate change
5. New research about facial recognition turns common wisdom on its head
6. New discoveries about brain-hand connection sought to improve therapies, treatments, prosthetics
7. Expedition to undersea mountain yields new information about sub-seafloor structure
8. Consumers need simple, concise messages about benefits of phytonutrients
9. Whats in a surname? New study explores what the evolution of names reveals about China
10. Analysis raises atmospheric, ecologic and economic doubts about forest bioenergy
11. Fruit flies provide new knowledge about uninhibited cell growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by ... Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to ... USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at ... ... MarketsandMarkets Logo ...
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):
(Date:8/10/2017)... Wash., Aug. 10, 2017   BioLife Solutions , ... manufacturer and marketer of proprietary clinical grade cell and ... media ("BioLife" or the "Company"), today reported operational ... months ended June 30, 2017. Revenue from ... $2.6 million in the second quarter of 2017, an ...
(Date:8/8/2017)... ... August 08, 2017 , ... ... and personalized medicine, today announced the launch of its second generation PD-L1 expression ... generation PD-L1 test, enabling highly sensitive and specific profiling and monitoring of PD-L1 ...
(Date:8/8/2017)... , ... August 08, 2017 , ... ... used to extract quantitative information from individual cells—join together at ISAC’s CYTO Innovation ... Arbor-based Akadeum Life Science, Inc.’s microbubble technology rose to the top as the ...
(Date:8/7/2017)... (PRWEB) , ... August 07, 2017 , ... ... that Dr. Michael A. Eldon, the former Vice President of Clinical Pharmacology at ... thirty-five years of experience in the pharmaceutical industry, has joined the firm as ...
Breaking Biology Technology: